Product correctly added to cart.

discount label
Canertinib dihydrochloride
View 3D

Targetmol logo

Canertinib dihydrochloride

CAS: 289499-45-2

Ref. TM-T2501

5mg
38.00 €
10mg
52.00 €
50mg
74.00 €
1ml*10 (DMSO)
51.00 €
Estimated delivery in United States, on Tuesday 28 May 2024

Product Information

Name:
Canertinib dihydrochloride
Synonyms:
  • CI-1033 dihydrochloride, PD-183805 dihydrochloride, Canertinib
  • 2-Propenamide, N-[4-[(3-chloro-4-fluorophenyl)amino]-7-[3-(4-morpholinyl)propoxy]-6-quinazolinyl]-, dihydrochloride
  • 2-Propenamide, N-[4-[(3-chloro-4-fluorophenyl)amino]-7-[3-(4-morpholinyl)propoxy]-6-quinazolinyl]-, hydrochloride (1:2)
  • Canertinib 2HCl
  • Ci 1033
  • N-[4-[(3-Chloro-4-fluorophenyl)amino]-7-(3-morpholin-4-ylpropoxy)quinazolin-6-yl]prop-2-enamide dihydrochloride
  • N-{4-[(3-chloro-4-fluorophenyl)amino]-7-[2-(morpholin-4-yl)ethoxy]quinazolin-6-yl}prop-2-enamide dihydrochloride
  • N-{4-[(3-chloro-4-fluorophenyl)amino]-7-[3-(morpholin-4-yl)propoxy]quinazolin-6-yl}prop-2-enamide dihydrochloride
  • Pd 183805
Description:

Canertinib dihydrochloride (PD-183805 dihydrochloride) is the hydrochloride salt of an orally bio-available quinazoline with potential antineoplastic and radiosensitizing activities.

Brand:
Targetmol
Long term storage:
Notes:

Chemical properties

Molecular weight:
558.86
Formula:
C24H27Cl3FN5O3
Purity:
99.23%
Color/Form:
Solid
MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code:

Hazard Info

UN Number:
EQ:
Class:
H Statements:
P Statements:
Forbidden to fly:
Hazard Info:
Packing Group:
LQ:

Technical inquiry about: TM-T2501 Canertinib dihydrochloride

Please use instead the cart to request a quotation or an order

If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.

* Mandatory fields.
Welcome to CymitQuimica!We use cookies to enhance your visit. We do not include advertising.

Please see our Cookies Policy for more details or adjust your preferences in "Settings".